Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Page 22 Page 23 Page 24 Page 25 Page 26 Page 27 Page 28 Page 29 Page 30 Page 31 Page 3216 Ensuring patients have access to innovative treatments and cures requires effective advocacy at all levels of government, including the state level. Accordingly, AdvaMed’s State Government Affairs team works to engage state lawmakers and regulators to advance our policy goals. In 2015, this included hosting a hearing by the California Assembly Select Committee on Biotechnology at the AdvaMed 2015 conference in San Diego focused on examining the state of the medical technology sector in California and policies influencing its continued vitality. Often working in concert with state and local medical technology groups, the team marked key successes across the nation: COVERAGE & REIMBURSEMENT In 2015, successful AdvaMed advocacy led to improved health technology assessment processes in New York and Washington to help protect patient access to life-changing innovations. This included passage of legislation in New York establishing advisory committee input on benefit coverage decisions. In Washington, AdvaMed was able to engage a broad group of stakeholders to help win a requirement for open meetings by one of the state’s technology assessment bodies, thus increasing transparency of the assessment process. In Utah, AdvaMed advocacy also helped defeat a proposal that would have instituted a new tax on device manufacturers to offset the cost of Medicaid expansion. ENVIRONMENTAL AdvaMed continued to fight efforts by state and local governments – in California in particular but in other states as well – to impose costly manufacturer take-back programs for home-generated medical sharps waste and batteries. In Connecticut and Texas, AdvaMed advocacy contributed to the defeat of legislation that would have placed the onus for battery disposal on medtech manufacturers. DISTRIBUTION AdvaMed sought to mitigate the burden of changes to medical device distribution regulations under consideration by the Louisiana legislature. The Association was able to secure appointment of a device industry representative to the state board charged with implementing the law, and supported successful legislation establishing a study committee on device distribution. The study report included several AdvaMed recommendations. AdvaMed’s State Medical Technology Alliance (SMTA), a grow- ing network of state and regional trade associations, bolsters the industry’s grassroots reach and ability to engage effectively with legislators at the state and federal levels. In March, SMTA members participated in an annual Capitol Hill fly-in to engage with their congressional delegations on important topics, including the urgent need for relief from the innovation- crushing medical device tax. ADVOCACYACROSS 50 STATES S T A T E A F F A I R S Connecticut State Senator Ted Kennedy, Jr. (at left) receives a cerebral oximeter demo during a tour of CAS Medical Systems, arranged by AdvaMed and Thomas Patton, president and CEO of the company (at right), accompanied by Barry Farbrother, board member at the Biomedical Engineering Alliance & Consortium (center). AdvaMed Chairman Vince Forlenza, chairman, president and CEO of BD, accepts from California State Assembly members a framed resolution by the legislative body commending AdvaMed for its outstanding advocacy on behalf of the medical technology industry in the state and nationwide. State Medical Technology Alliance A D V A M E D 2 0 1 5 A N N U A L R E P O R T